Το πράσινο φως για την εισαγωγή προς διαπραγμάτευση στην Κατηγορία Τίτλων Σταθερού Εισοδήματος της Ρυθμιζόμενης Αγοράς του Χρηματιστηρίου Αθηνών έως 500.000 κοινών ανωνύμων ομολογιών της ΜΥΤΙΛΗΝΑΙΟΣ έδωσε το Χρηματιστήριο Αθηνών.
Το πράσινο φως για την εισαγωγή προς διαπραγμάτευση στην Κατηγορία Τίτλων Σταθερού Εισοδήματος της Ρυθμιζόμενης Αγοράς του Χρηματιστηρίου Αθηνών έως 500.000 κοινών ανωνύμων ομολογιών της ΜΥΤΙΛΗΝΑΙΟΣ έδωσε το Χρηματιστήριο Αθηνών.
Ο Όμιλος TITAN ανακοινώνει την ολοκλήρωση της πράσινης επένδυσης ύψους 26 εκατ. ευρώ στο εργοστάσιο τσιμέντου στο Καμάρι Βοιωτίας, ένα σημαντικό ορόσημο στο πρόγραμμα των δράσεών του για τη μείωση εκπομπών διοξειδίου του άνθρακα.
Βιώσιμες χρηματοδοτήσεις ύψους 3 δισ. ευρώ σχεδιάζει η Alpha Bank για την τριετία 2023-2025, στο πλαίσιο της στρατηγικής της για υποστήριξη των ευρωπαϊκών και εθνικών στόχων βιώσιμης ανάπτυξης.
Για «ανάπτυξη σε κάθε περίπτωση» έκανε λόγο ο πρόεδρος του διοικητικού συμβουλίου της Τράπεζας Πειραιώς Γιώργος Χαντζηνικολάου, προβλέποντας ότι «οι καλύτερες μέρες για την ελληνική οικονομία και το ελληνικό τραπεζικό σύστημα είναι μπροστά μας».
Nvidia announced Monday that it is partnering with Snowflake to offer generative AI technology to the cloud-based data warehousing company’s customers.
British luxury carmaker Aston Martin unnerved investors on Tuesday by leaving out a sales volume target as it stuck to its medium-term financial goals.
Eli Lilly’s experimental drug helped patients lose up to 24% of their weight after almost a year, the highest reduction seen in the obesity treatment space to date, according to new mid-stage clinical trial results released Monday.
EV charging stocks were rallying early Tuesday in response to the latest news about companies switching over to use Tesla -style EV charging plugs.
Shein, the fast-fashion e-commerce juggernaut, is poised to keep gobbling up market share in the U.S., according to UBS .
Lucid ‘s largest shareholder is showing growing support for its electric vehicle investment.
Delta Air Lines on Tuesday raised its second-quarter forecast and estimated full-year adjusted earnings of $6 a share, at the high end of estimates it gave last April as strong travel demand and trade-ups to more expensive fare classes continue to drive growth.
Baidu said Tuesday the artificial intelligence model underpinning its chatbot outperformed OpenAI’s ChatGPT in several key areas.
Walgreens Boots Alliance on Tuesday slashed its full-year earnings guidance as it fell short of Wall Street expectations for its fiscal third quarter due to lower consumer spending and a drop in demand for Covid vaccines and testing.
Pfizer Inc said it is scrapping its once-a-day experimental obesity pill because of concerns about liver safety, but will continue developing its other obesity pill, the twice daily treatment danuglipron, as it races to rival the success of other weight loss treatments.
British luxury carmaker Aston Martin has reached a deal that will give U.S. electric vehicle (EV) maker Lucid Group a 3.7% stake in the company in return for access to its “high performance” technology, Aston Martin said on Monday.
PacWest Bancorp said on Monday it was selling a $3.54 billion lender finance loan portfolio to asset management firm Ares Management, in an attempt to boost liquidity at the U.S. regional lender, sending its shares up nearly 5%.
IBM is buying software company Apptio in a $4.6 billion all-cash deal. The company says the acquisition will advance IBM’s automation capabilities.
Novo Nordisk on Sunday said a late-stage trial found that a high-dose oral version of its drug semaglutide helped overweight or obese adults lose 15% of their body weight, which is in line with recent results for other experimental obesity pills.
Workers at dozens of U.S. Starbucks locations held strikes on Sunday to express their outrage over accusations by the baristas’ union that managers at several U.S. cafes removed rainbow flags and decorations supporting LGBTQ+ Pride month.
Gilead Sciences has received a positive response from the European Medicines Agency’s Committee for Medicinal Products for Human Use on an additional indication for the use of its antibody-drug conjugate Trodelvy in certain types of pre-treated breast cancer.